Sangamo BioSciences (SGMO) Market Capitalization to Book Value Ratio
Sangamo Therapeutics (SGMO) possesses a unique gene modification system, outsourcing a portion of its production cycles and initial testing to external contractors. Management is currently revising its strategy amid a funding shortage, seeking to monetize its proprietary developments. This daily price chart at the -4.56 level illustrates the price action of an asset whose revenue is based on collaborations with industry behemoths in the field of treating rare pathologies.
%20Capitalization%20to%20Book%20Value%20Ratio&width=1200&height=400&colorIndex=0&v=mvx9zauv.4e-7b561vk&start=20220704&end=20261101&filename=GURU_Markets_-_SGMO_-_Sangamo-Therapeutics_-_Capitalization-to-Book-Value-Ratio "SGMO: sangamo.com Market Value to Book Value Ratio 07/04/2022 - 05/09/2026 | 👁️GURU.Markets👁️")
Summary analytical data breakdowns for Sangamo Therapeutics Inc. (SGMO)
- market value and analyst target forecast:
- market capitalization details:
- balance sheet net asset value indicators:
- debt and solvency information:
Debt to Equity Sangamo Therapeutics|SGMO - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Capital Sangamo|SGMO - Company Aggregate Debts|Debt to Book Capitalization Ratio Sangamo|SGMO - Company Long-Term Indebtedness|Company Short-Term Debts Sangamo Therapeutics|Quick Ratio sangamo.com
- earnings and market multiples details:
Initial company analysis:Sangamo Therapeutics
Investors use this ratio to determine asset overvaluation by assessing the company's market value relative to its equity. Analyzing the historical relationship between market cap and book value reveals how the valuation of Sangamo Therapeutics (SGMO) depends on the value of its intellectual property amid a lack of retail revenue and stringent FDA regulatory constraints on clinical trial timelines.
Key competitors
Tempus Labs (TEM) - Market Value to Book Value Ratio|Market-to-Book Ratio qiagen.com (QGEN)|IONS (Ionis) - Market Capitalization to Book Value Ratio|Capitalization to Book Value Ratio RGEN (Repligen Corp)|Market Value to Book Value Ratio Avidity (RNA)|CRISPR - Capitalization to Book Value Ratio|Market Capitalization to Book Value Ratio WGS (GeneDx Holdings Corp.)|Market Capitalization to Book Value Ratio ultragenyx.com RARE|BEAM - Market Value to Book Value Ratio|Market Capitalization to Book Value Sarepta Therapeutics SRPT|TWST: Market Capitalization to Book Value Ratio|10x (TXG) - Market Capitalization to Book Value Ratio|Market Value to Book Value Ratio Intellia Therapeutics|Capitalization to Book Value Ratio STOK (stoketherapeutics.com)|Market Capitalization to Book Value Ratio BLFS|Wave Life Sciences Ltd (WVE) - Market Value to Equity Ratio|Market Capitalization to Book Value Ratio MAZE (Maze Tx)|Market Capitalization to Book Value Ratio Sionna Corp SION|PRME - Market Value to Book Value Ratio|tayshagtx.com (TSHA) - Market Cap to Net Assets Ratio|uniQure (QURE) - Market Value to Book Value Ratio|Market-to-Book Ratio MeiraGTx Holdings (MGTX)|Market Cap to Net Assets Ratio RGNX|SLDB: Market Value to Book Value|Market Cap to Net Assets Ratio OCGN (Ocugen, Inc.)|Market Cap to Book Value Multiple PACB|Market Capitalization to Book Value Ratio BNTC (Benitec Biopharma)|Market Value to Book Value DSGN|Rocket Pharmaceuticals Inc - Market Capitalization to Book Value Ratio|Market-to-Book Ratio 4D Molecular Corp|lexeotx.com (LXEO) - Market Value to Book Value Ratio|Korro Bio - Market Value to Book Value|EDIT (Editas Medicine) - Market Capitalization to Book Value Ratio|Market Capitalization to Book Value Ratio Silence Therapeutics PLC|Market Value to Book Value Ratio ProQR Therapeutics N.V. (PRQR)|CDXS: Market Capitalization to Net Assets|Market Capitalization to Book Value Ratio NAUT (Nautilus Bio)|metagenomi.co (MGX) - Market-to-Book Ratio|DTIL: Market Cap to Net Assets Ratio|GBIO - Market Capitalization to Book Value Ratio|BOLD (Boundless Bio, Inc) - Market Cap to Net Assets Ratio|XCUR: Market Cap to Book Value Multiple|IMNN (Imunon Inc) - Market Capitalization to Book Value Ratio|RXi Pharmaceuticals (PHIO) - Market Capitalization to Book Value|Market Capitalization to Book Value Ratio MBIO|Market Cap to Net Assets Ratio transcodetherapeutics.com RNAZ|Market Value to Book Value Ratio Bionano Genomics BNGO|Market Capitalization to Book Value Applied DNA Corp (APDN)|BLUE - Market Value to Book Value Ratio|Market Capitalization to Book Value ImmunoPrecise Antibodies IPA|OMGA: Market Capitalization to Book Value Ratio|Market Value to Equity Ratio Singular Genomics Systems, Inc. OMIC|Market Value to Book Value Ratio Regulus Therapeutics Inc|Market Cap to Net Assets Ratio Syros Pharmaceuticals, Inc (SYRS)|Market Value to Book Value Ratio Telesis Bio, Inc. (TBIO)|TCON - Market-to-Book Ratio|Market Capitalization to Book Value Ratio UBX (Unity Biotechnology, Inc.)